Recruiting

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(12 sites)

Australia

Royal Prince Alfred, Camperdown, New South Wales

John Hunter Hospital, Newcastle, New South Wales

Mater Misericordiae, South Brisbane, Queensland

Gold Coast University Hospital, Southport, Queensland

Women's and Children's Hospital, North Adelaide, South Australia

Monash Health, Clayton, Victoria

Mercy Hospital, Heidelberg, Victoria

Royal Women's Hospital, Parkville, Victoria

Joan Kirner Hospital, Saint Albans, Victoria

New Zealand

Auckland Hospital, Auckland

Middlemore Hospital, Auckland

Wellington Regional Hospital, Wellington